Xifeng Jiang
27 Taiping Road
Taiping, 100850, China
Taiping, 100850, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
An effective conjugation strategy for designing short peptide-based HIV-1 fusion inhibitors.
Journal: Organic & biomolecular chemistry
Published: July 26, 2016
Site-specific Isopeptide Bridge Tethering of Chimeric gp41 N-terminal Heptad Repeat Helical Trimers for the Treatment of HIV-1 Infection.
Journal: Scientific reports
Published: July 08, 2016
Design, synthesis, and evaluation of water-soluble morpholino-decorated paclitaxel prodrugs with remarkably decreased toxicity.
Journal: Bioorganic & medicinal chemistry letters
Published: February 25, 2016
An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications.
Journal: Chemical science
Published: October 25, 2015
DNA Triplex-Based Complexes Display Anti-HIV-1-Cell Fusion Activity.
Journal: Nucleic acid therapeutics
Published: July 21, 2015
De novo design of isopeptide bond-tethered triple-stranded coiled coils with exceptional resistance to unfolding and proteolysis: implication for developing antiviral therapeutics.
Journal: Chemical science
Published: June 19, 2015
Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: a promising strategy for discovering new antiviral therapeutics.
Journal: Journal of medicinal chemistry
Published: August 27, 2014
The use of hairpin DNA duplexes as HIV-1 fusion inhibitors: synthesis, characterization, and activity evaluation.
Journal: European journal of medicinal chemistry
Published: February 17, 2014
Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.
Journal: The Journal of antimicrobial chemotherapy
Published: February 07, 2014
DNA duplexes with hydrophobic modifications inhibit fusion between HIV-1 and cell membranes.
Journal: Antimicrobial agents and chemotherapy
Published: July 31, 2013
Increase of anti-HIV activity of C-peptide fusion inhibitors using a bivalent drug design approach.
Journal: Bioorganic & medicinal chemistry letters
Published: May 30, 2013
Last Updated: 09/26/2026